Literature DB >> 33511888

Reply to letter to editor by McCullough.

Amandeep Goyal1, Pankaj Bansal2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33511888      PMCID: PMC7877975          DOI: 10.1080/07853890.2021.1878273

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


× No keyword cloud information.
  5 in total

Review 1.  Hydroxychloroquine neuromyotoxicity.

Authors:  M Stein; M J Bell; L C Ang
Journal:  J Rheumatol       Date:  2000-12       Impact factor: 4.666

2.  Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19.

Authors:  Alexandre B Cavalcanti; Fernando G Zampieri; Regis G Rosa; Luciano C P Azevedo; Viviane C Veiga; Alvaro Avezum; Lucas P Damiani; Aline Marcadenti; Letícia Kawano-Dourado; Thiago Lisboa; Debora L M Junqueira; Pedro G M de Barros E Silva; Lucas Tramujas; Erlon O Abreu-Silva; Ligia N Laranjeira; Aline T Soares; Leandro S Echenique; Adriano J Pereira; Flávio G R Freitas; Otávio C E Gebara; Vicente C S Dantas; Remo H M Furtado; Eveline P Milan; Nicole A Golin; Fábio F Cardoso; Israel S Maia; Conrado R Hoffmann Filho; Adrian P M Kormann; Roberto B Amazonas; Monalisa F Bocchi de Oliveira; Ary Serpa-Neto; Maicon Falavigna; Renato D Lopes; Flávia R Machado; Otavio Berwanger
Journal:  N Engl J Med       Date:  2020-07-23       Impact factor: 91.245

3.  A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.

Authors:  David R Boulware; Matthew F Pullen; Ananta S Bangdiwala; Katelyn A Pastick; Sarah M Lofgren; Elizabeth C Okafor; Caleb P Skipper; Alanna A Nascene; Melanie R Nicol; Mahsa Abassi; Nicole W Engen; Matthew P Cheng; Derek LaBar; Sylvain A Lother; Lauren J MacKenzie; Glen Drobot; Nicole Marten; Ryan Zarychanski; Lauren E Kelly; Ilan S Schwartz; Emily G McDonald; Radha Rajasingham; Todd C Lee; Kathy H Hullsiek
Journal:  N Engl J Med       Date:  2020-06-03       Impact factor: 91.245

4.  Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians (Version 1).

Authors:  Amir Qaseem; Jennifer Yost; Itziar Etxeandia-Ikobaltzeta; Matthew C Miller; George M Abraham; Adam Jacob Obley; Mary Ann Forciea; Janet A Jokela; Linda L Humphrey; Robert M Centor; Rebecca Andrews; Thomas A Bledsoe; Ray Haeme; Devan L Kansagara; Maura Marcucci
Journal:  Ann Intern Med       Date:  2020-05-13       Impact factor: 25.391

Review 5.  Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019.

Authors:  Pankaj Bansal; Amandeep Goyal; Austin Cusick; Shubham Lahan; Harpal S Dhaliwal; Poonam Bhyan; Pradnya Brijmohan Bhattad; Fawad Aslam; Sagar Ranka; Tarun Dalia; Lovely Chhabra; Devang Sanghavi; Bhavin Sonani; John M Davis
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.